Role of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia

Author(s):  
B ALEXANDER ◽  
D WECHSLER ◽  
J HERMAN ◽  
T BRAUN ◽  
G YANIK ◽  
...  
2005 ◽  
Vol 63 (4) ◽  
pp. 1191-1196 ◽  
Author(s):  
Brian M. Alexander ◽  
Daniel Wechsler ◽  
Thomas M. Braun ◽  
John Levine ◽  
Joseph Herman ◽  
...  

Blood ◽  
2015 ◽  
Vol 125 (16) ◽  
pp. 2486-2496 ◽  
Author(s):  
Nathalie Dhédin ◽  
Anne Huynh ◽  
Sébastien Maury ◽  
Reza Tabrizi ◽  
Kheira Beldjord ◽  
...  

Key Points SCT in first complete remission is associated with 69.5% 3-year overall survival in high-risk ALL adult patients treated with intensified pediatric-like protocol. Poor early MRD response is a powerful tool to select patients who may benefit from SCT in first complete remission.


Sign in / Sign up

Export Citation Format

Share Document